So-Young is a medical aesthetics platform and clinic chain operator in China, focused on non-surgical, light aesthetic treatments — skin rejuvenation, anti-aging, and body contouring. So-Young operates through two interconnected channels: an online platform (mobile app, WeChat mini program, website) where consumers browse treatments, read reviews, and book appointments, and a growing chain of branded offline clinic centers called So-Young Clinic. As of year-end 2025, So-Young operated 49 smaller-format clinics (200–500 square meters) across 15 cities, positioned in high-traffic urban commercial locations. So-Young explicitly targets high-frequency, lower-spend-per-visit behavior — core members visit roughly 6–8 times per year — which differentiates it from large-format surgical chains like Mylike and Yestar that rely on infrequent, higher-value procedures. So-Young generates revenue across three segments: Aesthetic Treatment Services (offline clinic procedures, now over 50% of revenue and the primary growth driver), Information and Reservation Services (the legacy online platform where third-party practitioners pay listing and referral fees, currently in structural decline), and Sales of Medical Products through Wuhan Miracle, a subsidiary that manufactures laser and optoelectronic devices and distributes injectables. So-Young's long-term strategy centers on expanding to 1,000 clinic centers over 8–10 years, supplemented by a capital-light franchise model, deepening upstream supply chain control through Wuhan Miracle, and concentrating its treatment portfolio on a small number of high-volume procedures.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →